1,694 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Triasima Portfolio Management inc.

Triasima Portfolio Management inc. acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,694 shares of the biopharmaceutical company’s stock, valued at approximately $1,780,000. Other large […]

Leave a Reply

Your email address will not be published.

Previous post Varma Mutual Pension Insurance Co Has $87.02 Million Position in Visa Inc. (NYSE:V)
Next post Prestige Wealth Management Group LLC Boosts Stock Position in Chubb Limited (NYSE:CB)